Hochschule Zittau Görlitz

Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrow

by Duda, D. G.
Published in Journal of Clinical Investigation (2005)

Premetastatic Lung "Niche": Is Vascular Endothelial Growth Factor Receptor 1 Activation Required?

by Duda, D. G., Jain, R. K.
Published in Cancer Research (2010)

Visualizing anti-tumor immune responses in vivo

by Perentes, J. Y., Duda, D. G., Jain, R. K.
Published in Disease Models and Mechanisms (2009)

Seeds and Soil: Unraveling the Role of Local Tumor Stroma in Distant Metastasis

by Duda, D. G., Ancukiewicz, M., Isakoff, S. J., Krop, I. E., Jain, R. K.
Published in JNCI Journal of the National Cancer Institute (2014)

Translation of Anticancer Efficacy From Nonclinical Models to the Clinic

by Stroh, M, Duda, D G, Takimoto, C H, Yamazaki, S, Vicini, P
Published in CPT Pharmacometrics Syst. Pharmacol. (2014)

Benefits of Vascular Normalization Are Dose and Time Dependent--Letter

by Huang, Y., Stylianopoulos, T., Duda, D. G., Fukumura, D., Jain, R. K.
Published in Cancer Research (2013)

Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy

by Huang, Y., Goel, S., Duda, D. G., Fukumura, D., Jain, R. K.
Published in Cancer Research (2013)

Neovascularization After Irradiation: What is the Source of Newly Formed Vessels in Recurring Tumors?

by Kozin, S. V., Duda, D. G., Munn, L. L., Jain, R. K.
Published in JNCI Journal of the National Cancer Institute (2012)

CXCL12 (SDF1 )-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?

by Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., Jain, R. K.
Published in Clinical Cancer Research (2011)

Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation

by Kozin, S. V., Kamoun, W. S., Huang, Y., Dawson, M. R., Jain, R. K., Duda, D. G.
Published in Cancer Research (2010)

Differential circulation kinetics during antiangiogenic therapy of four distinct blood cell populations expressing endothelial markers

by Duda, D. G., Cohen, K. S., Di Tomaso, E., Scadden, D. T., Willett, C. G., Jain, R. K.
Published in Journal of Clinical Oncology (2006)

Malignant cells facilitate lung metastasis by bringing their own soil

by Duda, D. G., Duyverman, A. M. M. J., Kohno, M., Snuderl, M., Steller, E. J. A., Fukumura, D., Jain, R. K.
Published in Proceedings of the National Academy of Sciences (2010)

Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells

by Samuel, R., Daheron, L., Liao, S., Vardam, T., Kamoun, W. S., Batista, A., Buecker, C., Schafer, R., Han, X., Au, P., Scadden, D. T., Duda, D. G., Fukumura, D., Jain, R. K.
Published in Proceedings of the National Academy of Sciences (2013)

Exploratory Analysis of Early Toxicity of Sunitinib in Advanced Hepatocellular Carcinoma Patients: Kinetics and Potential Biomarker Value

by Zhu, A. X., Duda, D. G., Ancukiewicz, M., di Tomaso, E., Clark, J. W., Miksad, R., Fuchs, C. S., Ryan, D. P., Jain, R. K.
Published in Clinical Cancer Research (2011)

A phase II study of neoadjuvant bevacizumab and radiation therapy for resectable soft tissue sarcomas.

by Yoon, S. S., Chen, Y., Karl, D., Choy, E., Harmon, D. C., Kambadakone, A., Sahani, D., Duda, D. G., Jain, R. K., DeLaney, T. F.
Published in Journal of Clinical Oncology (2010)

Characterization of blood vessels in brain autopsies of GBM patients who received antiangiogenic treatment

by di Tomaso, E., Frosch, M. P., Auluck, P. K., Cahill, D., Duda, D. G., Plotkin, S. R., Loeffler, J. S., Sorensen, A. G., Batchelor, T. T., Jain, R. K.
Published in Journal of Clinical Oncology (2008)

A comparative study of circulating endothelial cells (CECs) and circulating progenitor cells (CPCs) kinetics in four multidisciplinary phase II studies of antiangiogenic agents

by Duda, D. G., Cohen, K. S., Ancukiewicz, M., di Tomaso, E., Zhu, A. X., Penson, R. T., Horowitz, N. S., Batchelor, T. T., Willett, C. G., Jain, R. K.
Published in Journal of Clinical Oncology (2008)

Sunitinib monotherapy in patients with advanced hepatocellular carcinoma (HCC): Insights from a multidisciplinary phase II study

by Zhu, A. X., Sahani, D. V., di Tomaso, E., Duda, D. G., Catalano, O. A., Ancukiewicz, M., Blaszkowsky, L. S., Abrams, T. A., Ryan, D. P., Jain, R. K.
Published in Journal of Clinical Oncology (2008)

Correlation of blood and physiologic markers with effect of bevacizumab (BV) with chemoradiation therapy in rectal cancer (RC)

by Willett, C. G., Duda, D. G., Xu, L., diTomaso, E., Boucher, Y., Czito, B., Ancukiewicz, M., Clark, J., Carroll, M., Lauwers, G., Jain, R. K.
Published in Journal of Clinical Oncology (2008)

A phase II trial of AZD2171 (cediranib), an oral pan-VEGF receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

by Batchelor, T., Sorensen, A. G., Ancukiewicz, M., Duda, D. G., Louis, D. N., Plotkin, S. R., Ivy, P., Wen, P. Y., Loeffler, J. S., Jain, R.
Published in Journal of Clinical Oncology (2007)